https://www.youtube.com/watch?v=IAsQvFaA84o

OncoMatriX™

OncoMatriX™ is an oncology-centric cloud operating system designed to facilitate the analysis and processing of radiation physics, biological data, and clinical workflow powered by artificial intelligence and Monte Carlo computational kernels. It is typically used in bioinformatics, radiation oncology, and statistical data analysis, applying powerful cloud computing and advanced statistical methods to biological and charged particle data. This provides researchers with a powerful toolset for analyzing complex biological data, such as DNA sequences and protein structures, beam trajectories in tissue and their interaction with malignant and healthy cells and can help uncovering new insights into the workings of living organisms. It is an enabling state-of-the-art technology for advancing our understanding of biology and improving our ability to develop new medical treatments and therapies.

OncoMatriX™, is being developed to launch with our Artemis™ platform. This will revolutionize the way radiation treatment and research systems are operated, monitored, and maintained. OncoMatriX™ seamlessly operates in the background, continuously tracking and storing critical performance parameters without requiring user intervention. Leveraging advanced AI and Machine Learning algorithms, OncoMatriX™ interprets performance data to identify trends and predict potential failures with high accuracy. This predictive maintenance capability prevents system downtime and allows for rapid response and remote resolution, saving time and labor for users. Automated monitoring ensures that the system remains in peak condition, enhancing overall efficiency and reliability, and significantly decreasing the possibility of unexpected downtime.

OncoMatriX™ will also offer robust data management solutions for quality assurance and research purposes. Quality assurance tests are securely stored in the system’s AI-monitored database, facilitating easy tracking and report development for maintenance and audit purposes. For clinical trials and multi-site research purposes, OncoMatriX™ provides a centralized data repository, enabling seamless sharing of test protocols and data, while offering enhanced and automated design and management of experiments, advanced data analytics, and Machine Learning-driven statistics and reporting. The integrated AI capabilities help identify trends swiftly, streamlining the process of research paper publication development and efficiently accelerating research outcomes. While OncoMatriX™ operates locally, it also offers cloud-based options for remote access, ensuring flexibility and convenience for its users.